WhiteSwell

About:

WhiteSwell is dedicated to advancing treatment of acute decompensated heart failure .

Website: http://whiteswell.com/

Top Investors: RA Capital Management, InCube Ventures

Description:

WhiteSwell is a science-driven company dedicated to improving the treatment of acute decompensated heart failure (ADHF), which is a leading cause of hospitalization and emergency room visits. The WhiteSwell team investigated the therapeutic potential of the lymphatic system in order to address this significant clinical need. Its solution is unique in that it allows fluid removal from both the interstitial and intravascular compartments.

Total Funding Amount:

$30M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ballybrit, Galway, Ireland

Founded Date:

2014-01-01

Founders:

Yaacov Nitzan

Number of Employees:

11-50

Last Funding Date:

2018-12-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai